Cargando…

Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study

BACKGROUND: Matrix metalloproteinase-7 (MMP7) is markedly expressed in patients with chronic kidney disease; its expression in dialysate and role in patients undergoing peritoneal dialysis (PD) have not been well established. METHODS: Participants undergoing PD from June 1st, 2015, to June 30th, 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zhiwen, Tian, Jianwei, Zhang, Fen, Zhong, Xiaohong, Zhang, Tingting, Yi, Zhixiu, Lin, Yanhong, Yang, Cong, Tang, Dan, Gong, Nirong, Ai, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169244/ https://www.ncbi.nlm.nih.gov/pubmed/37181812 http://dx.doi.org/10.1155/2023/5380764

Ejemplares similares

High-Salt Diet Accelerated the Decline of Residual Renal Function in Patients With Peritoneal Dialysis
por: Gong, Nirong, et al.
Publicado: (2021)

Hypokalemia Duration in the First Year Associated with Subsequent Peritoneal Dialysis-Associated Peritonitis: A Multicenter Retrospective Cohort Study
por: Huo, Zhihao, et al.
Publicado: (2022)

Sacubitril-Valsartan Increases Ultrafiltration in Patients Undergoing Peritoneal Dialysis: A Short-Term Retrospective Self-Controlled Study
por: Zhang, Fen, et al.
Publicado: (2022)

Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis
por: Kunin, Margarita, et al.
Publicado: (2015)

MMP‐7 affects peritoneal ultrafiltration associated with elevated aquaporin‐1 expression via MAPK/ERK pathway in peritoneal mesothelial cells
por: Yin, Yue, et al.
Publicado: (2021)

Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome
por: Shao, Qiuyuan, et al.
Publicado: (2018)

Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure
por: Kunin, Margarita, et al.
Publicado: (2019)

A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients
por: Chou, Che-Yi, et al.
Publicado: (2021)

Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure
por: Kihm, Lars P., et al.
Publicado: (2011)

Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis
por: Timóteo, Ana Teresa, et al.
Publicado: (2023)

Current apparent treatment‐resistant hypertension in patients undergoing peritoneal dialysis: A multi‐center cross‐sectional study
por: Li, Dan, et al.
Publicado: (2022)

Peritoneal and Urinary Sodium Removal in Refractory Congestive Heart Failure Patients Included in an Ambulatory Peritoneal Dialysis Program: Valuable for Monitoring the Course of the Disease
por: Miñana, Gema, et al.
Publicado: (2023)

Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction
por: Pavo, Noemi, et al.
Publicado: (2018)

The role of peritoneal ultrafiltration in the treatment of refractory congestive heart failure
por: Samoni, Sara, et al.
Publicado: (2015)

Ultrafiltration by Peritoneal Route in Refractory Chronic Congestive Cardiac Failure
por: Hedau, S., et al.
Publicado: (2018)

Case Report: Recurring Peritonitis and Dialysis Failure in a Toddler on Peritoneal Dialysis
por: Mohammed, Enas H., et al.
Publicado: (2021)

Peritoneal Dialysis or Haemodialysis for Kidney Failure?
por: Man Shrestha, Badri
Publicado: (2018)

Role of matrix metalloproteinases in tumour invasion: immunohistochemistry of peritoneum from peritoneal carcinomatosis
por: Falk, Peter, et al.
Publicado: (2018)

Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
por: Zhang, Wei, et al.
Publicado: (2022)

Development of a clinical risk score system for peritoneal dialysis-associated peritonitis treatment failure
por: Mao, Yuhe, et al.
Publicado: (2023)

Patterns of peritoneal dialysis catheter practices and technique failure in peritoneal dialysis: A nationwide cohort study
por: Lanot, Antoine, et al.
Publicado: (2019)

A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study
por: Sun, Chien-Yao, et al.
Publicado: (2019)

Hepatocyte growth factor signalizes peritoneal membrane failure in peritoneal dialysis
por: Bernardo, Ana Paula, et al.
Publicado: (2014)

Neutrophil-to-Lymphocyte Ratio and Treatment Failure in Peritoneal Dialysis-Associated Peritonitis
por: He, Peng, et al.
Publicado: (2021)

Hyperlipidemia and mortality in patients on peritoneal dialysis
por: Feng, Xiaoran, et al.
Publicado: (2022)

Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022)

Left Heart Failure Caused by Capacity Overload in Peritoneal Dialysis Patients
por: Zhang, Lin, et al.
Publicado: (2022)

Extracorporeal versus peritoneal ultrafiltration in diuretic-resistant congestive heart failure – a review
por: Wańkowicz, Zofia, et al.
Publicado: (2011)

Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis
por: Krediet, Raymond T.
Publicado: (2018)

Novel Predictors and Risk Score of Treatment Failure in Peritoneal Dialysis-Related Peritonitis
por: Liu, Xiang, et al.
Publicado: (2021)

Technique failure in peritoneal dialysis-related peritonitis: risk factors and patient survival
por: Yu, Jin, et al.
Publicado: (2023)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Peritoneal dialysis as therapeutic option in heart failure patients
por: Grossekettler, Leonie, et al.
Publicado: (2019)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Cost-Utility of Dialysis in Canada: Hemodialysis, Peritoneal Dialysis, and Nondialysis Treatment of Kidney Failure
por: Ferguson, Thomas W., et al.
Publicado: (2020)

Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Congestive heart failure
por: Zhao, Xuan
Publicado: (2019)

Protective measures against ultrafiltration failure in peritoneal dialysis patients
por: Aguirre, Anna Rita, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8pgkroqe4ham03oj1tf1m8v63n